149 related articles for article (PubMed ID: 37035965)
1. Non-invasive imaging of functional pancreatic islet beta-cell mass in people with type 1 diabetes mellitus.
Joshi SS; Singh T; Kershaw LE; Gibb FW; Dweck MR; Williams M; Idris I; Semple S; Forbes S; Newby DE; Reynolds RM
Diabet Med; 2023 Oct; 40(10):e15111. PubMed ID: 37035965
[TBL] [Abstract][Full Text] [Related]
2. Repeatability and reproducibility of cardiac manganese-enhanced magnetic resonance imaging.
Singh T; Joshi S; Meah MN; Spath NB; Papanastasiou G; Kershaw LE; Baker AH; Dweck MR; Newby DE; Semple SI
Sci Rep; 2023 Feb; 13(1):3366. PubMed ID: 36849509
[TBL] [Abstract][Full Text] [Related]
3. Manganese-enhanced magnetic resonance imaging detects declining pancreatic β-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes.
Antkowiak PF; Stevens BK; Nunemaker CS; McDuffie M; Epstein FH
Diabetes; 2013 Jan; 62(1):44-8. PubMed ID: 22933107
[TBL] [Abstract][Full Text] [Related]
4. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic perfusion of healthy individuals and type 1 diabetic patients as assessed by magnetic resonance perfusion imaging.
Hirshberg B; Qiu M; Cali AM; Sherwin R; Constable T; Calle RA; Tal MG
Diabetologia; 2009 Aug; 52(8):1561-5. PubMed ID: 19488737
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.
Li YX; Sang YQ; Sun Y; Liu XK; Geng HF; Zha M; Wang B; Teng F; Sun HJ; Wang Y; Qiu QQ; Zang X; Wang Y; Wu TT; Jones PM; Liang J; Xu W
Int J Med Sci; 2020; 17(12):1673-1682. PubMed ID: 32714070
[No Abstract] [Full Text] [Related]
7. Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.
Antkowiak PF; Tersey SA; Carter JD; Vandsburger MH; Nadler JL; Epstein FH; Mirmira RG
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E573-8. PubMed ID: 19116376
[TBL] [Abstract][Full Text] [Related]
8. [
Carlbom L; Espes D; Lubberink M; Martinell M; Johansson L; Ahlström H; Carlsson PO; Korsgren O; Eriksson O
Diabetes; 2017 May; 66(5):1286-1292. PubMed ID: 28246291
[TBL] [Abstract][Full Text] [Related]
9. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes.
Williams AJ; Thrower SL; Sequeiros IM; Ward A; Bickerton AS; Triay JM; Callaway MP; Dayan CM
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2109-13. PubMed ID: 22879632
[TBL] [Abstract][Full Text] [Related]
11. Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus.
Kryvalap Y; Lo CW; Manuylova E; Baldzizhar R; Jospe N; Czyzyk J
J Biol Chem; 2016 Jan; 291(1):266-78. PubMed ID: 26578518
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
Brooks AM; Oram R; Home P; Steen N; Shaw JA
Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
[TBL] [Abstract][Full Text] [Related]
14. Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
Van Dalem A; Demeester S; Balti EV; Decochez K; Weets I; Vandemeulebroucke E; Van de Velde U; Walgraeve A; Seret N; De Block C; Ruige J; Gillard P; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetologia; 2015 Dec; 58(12):2753-64. PubMed ID: 26409458
[TBL] [Abstract][Full Text] [Related]
15. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of pancreatic beta-cell area in humans.
Meier JJ; Menge BA; Breuer TG; Müller CA; Tannapfel A; Uhl W; Schmidt WE; Schrader H
Diabetes; 2009 Jul; 58(7):1595-603. PubMed ID: 19509022
[TBL] [Abstract][Full Text] [Related]
17. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
McVean J; Forlenza GP; Beck RW; Bauza C; Bailey R; Buckingham B; DiMeglio LA; Sherr JL; Clements M; Neyman A; Evans-Molina C; Sims EK; Messer LH; Ekhlaspour L; McDonough R; Van Name M; Rojas D; Beasley S; DuBose S; Kollman C; Moran A;
JAMA; 2023 Mar; 329(12):980-989. PubMed ID: 36826834
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.
Liu EH; Digon BJ; Hirshberg B; Chang R; Wood BJ; Neeman Z; Kam A; Wesley RA; Polly SM; Hofmann RM; Rother KI; Harlan DM
Diabetologia; 2009 Jul; 52(7):1369-80. PubMed ID: 19418039
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.
Normandin MD; Petersen KF; Ding YS; Lin SF; Naik S; Fowles K; Skovronsky DM; Herold KC; McCarthy TJ; Calle RA; Carson RE; Treadway JL; Cline GW
J Nucl Med; 2012 Jun; 53(6):908-16. PubMed ID: 22573821
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.
Tushuizen ME; Bunck MC; Pouwels PJ; Bontemps S; van Waesberghe JH; Schindhelm RK; Mari A; Heine RJ; Diamant M
Diabetes Care; 2007 Nov; 30(11):2916-21. PubMed ID: 17666465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
